Potential Impact of Nirsevimab on RSV Transmission and Medically Attended Lower Respiratory Tract Illness Caused by RSV: A Disease Transmission Model
Crossref DOI link: https://doi.org/10.1007/s40121-021-00566-9
Published Online: 2021-11-23
Published Print: 2022-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Voirin, Nicolas
Virlogeux, Victor
Demont, Clarisse
Kieffer, Alexia
Funding for this research was provided by:
Sanofi Pasteur
Text and Data Mining valid from 2021-11-23
Version of Record valid from 2021-11-23
Article History
Received: 23 August 2021
Accepted: 9 November 2021
First Online: 23 November 2021